Two headlines in Washington are driving the conversation around cannabis and hemp. A GOP-led congressional committee voted to block President Trump from moving forward with cannabis rescheduling. At the same time, Senator John Boozman said that if a strict federal hemp THC ban is enacted, “nobody will buy” those products. Both developments highlight how divided lawmakers remain on cannabis and hemp policy.
This episode of the TDR Trade to Black Podcast looks at what these moves mean for the industry and investors. We’re also joined by Dan from The Chart Guys, who will help break down a volatile week for cannabis stocks. Support levels have been tested, and with policy headlines driving much of the action, the big question is what comes next.
In rescheduling news, a House GOP spending bill contains language to block the Department of Justice from moving cannabis to Schedule III. Analysts note the Senate version does not include the provision, making it unlikely to survive conference. Existing protections such as the Rohrabacher–Farr Amendment remain in place, shielding state programs.
Senator Paul continues to promote raising hemp’s legal THC threshold from 0.3% to 1%, an issue tied to the upcoming farm bill. Industry stakeholders say federal inconsistency between hemp and marijuana definitions allows illicit products to exploit loopholes, while regulators consider broader enforcement actions. Paul argues consumers want hemp products with measurable THC content, but federal law remains unsettled.
State regulators report annual cannabis sales nearing $2 billion. Licensing delays and oversupply risks persist, but enforcement against unlicensed shops is accelerating. Upstate dispensaries average $3–4 million annually, downstate closer to $5 million. Cultivators use roughly 55% of licensed canopy, with further expansion planned in 2026.
Lastly, Dan from The Chart Guys highlights technical levels for MSOS: support at $4.04 and a gap to $3.79. He says a pullback of ~43% from recent highs is within normal retracement, but breaking below $4 would mark deeper weakness. NASDAQ-listed companies such as High Tide (HITI), Organigram (OGI), Village Farms (VFF), and SNDL are holding up better than OTC-listed peers. Upcoming High Tide earnings on Monday are expected to be a near-term catalyst.
